Strontium ranelate improves bone microarchitecture in osteoporosis

An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats

(2010) Pierre J. Marie et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Prolonged Treatments With Antiresorptive Agents and PTH Have Different Effects on Bone Strength and the Degree of Mineralization in Old Estrogen-Deficient Osteoporotic Rats

(2009) Zhiqiang Cheng et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis

(2008) C Roux et al.   ANNALS OF THE RHEUMATIC DISEASES

Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial

(2008) Jean-Yves Reginster et al.   ARTHRITIS AND RHEUMATISM

The Calcium-sensing Receptor Is Involved in Strontium Ranelate-induced Osteoclast Apoptosis

(2008) Anne S. Hurtel-Lemaire et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Selective Modification of Bone Quality by PTH, Pamidronate, or Raloxifene

(2008) Tara C Brennan et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response

(2008) G. J. Atkins et al.   OSTEOPOROSIS INTERNATIONAL

Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants

(2008) S. D. Bain et al.   OSTEOPOROSIS INTERNATIONAL

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

True Strength

(2006) Robert S. Weinstein   JOURNAL OF BONE AND MINERAL RESEARCH